Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of diseases, with a focus on genetic diseases. The company's product, Mepsevii (vestronidase alfa), is approved for the treatment of children and adults with Mucopolysaccharidosis VII. The company's biologics pipeline includes burosumab in clinical development for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia. The company's substrate replacement therapy pipeline includes UX007 in clinical development for the treatment of long-chain fatty acid oxidation disorders and glucose transporter type-1 deficiency syndrome.
  • TickerRARE
  • ISINUS90400D1081
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for RARE

ValuEngine Rating and Forecast Report for RARE

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for RARE

ValuEngine Rating and Forecast Report for RARE

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for RARE

ValuEngine Rating and Forecast Report for RARE

ValuEngine Rating and Forecast Report for RARE

ValuEngine Rating and Forecast Report for RARE

ValuEngine Rating and Forecast Report for RARE

ValuEngine Rating and Forecast Report for RARE

ValuEngine Rating and Forecast Report for RARE

ValuEngine Rating and Forecast Report for RARE

ValuEngine Rating and Forecast Report for RARE

ValuEngine Rating and Forecast Report for RARE

ResearchPool Subscriptions

Get the most out of your insights

Get in touch